Skip to main content
Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
64.92
-0.57 (-0.87%)
At close: Feb 21, 2025, 4:00 PM
64.80
-0.12 (-0.18%)
After-hours: Feb 21, 2025, 6:15 PM EST

Bio-Techne Revenue

Bio-Techne had revenue of $297.03M in the quarter ending December 31, 2024, with 8.96% growth. This brings the company's revenue in the last twelve months to $1.20B, up 4.46% year-over-year. In the fiscal year ending June 30, 2024, Bio-Techne had annual revenue of $1.16B with 1.97% growth.

Revenue (ttm)
$1.20B
Revenue Growth
+4.46%
P/S Ratio
8.58
Revenue / Employee
$392,136
Employees
3,050
Market Cap
10.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20241.16B22.36M1.97%
Jun 30, 20231.14B31.10M2.81%
Jun 30, 20221.11B174.57M18.75%
Jun 30, 2021931.03M192.34M26.04%
Jun 30, 2020738.69M24.69M3.46%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

TECH News

More News